Axsome Therapeutics Receives FDA Fast Track Designation for AXS-05 for Alzheimer s Disease Agitation

Monday, May 8, 2017 1 min read

Key Takeaway: Axsome Therapeutics Receives FDA Fast Track Designation for AXS-05 for Alzheimer s Disease Agitation

Full Press Release Details

Axsome Therapeutics Receives FDA Fast Track Designation for AXS-05 for Alzheimer s Disease Agitation.